NFE2L2 and cancer: However, many studies have reported that cancer cells can take advantage of the activation of the Nrf2/ARE signaling pathway to resist chemotherapy by attenuating the pro-oxidant and cytotoxic activities of chemotherapeutic agents [13,14].